NHS England to offer Daiichi Sankyo’s quizartinib for AML
The National Health Service (NHS) England has announced the routine commissioning of Daiichi Sankyo's quizartinib for acute myeloid leukaemia (AML) patients with the FLT3-ITD...
Some diabetes drugs may help lower risk
Share on PinterestThe rate of neurodegenerative conditions is growing globally, meaning that a lot of research is into prevention of these problems. There has...
Revealing New DNA Structures: A Breakthrough That Could Redefine Diabetes Treatment
Researchers discovered the crystal structure of an alternative DNA configuration within the insulin gene, providing insights into its role in diabetes. This breakthrough in...
Bioxytran’s Medical Breakthrough in Fighting All Viruses
Breakthrough was validated in the latest journal articleGalectins are essential for viral entry and a new target for drug developmentCarbohydrates were shown to neutralize...
Some diabetes meds might lower risk of dementia, Parkinson’s
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows. Photo by...
Frontline Combination Therapy Intensification May Improve Survival in NSCLC
At the 2024 European Society for Medical Oncology Congress (ESMO), CancerNetwork® spoke with Nicolas Girard, MD, about findings from the phase 2 RELATIVITY-104 study...
Innovative Cellular Therapeutics Announces the Publication of Groundbreaking GCC19CART™ Study to...
ROCKVILLE, Md., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Innovative Cellular Therapeutics, Inc. (ICT), a clinical-stage biotechnology company developing a comprehensive portfolio of chimeric antigen...
Citizens Memorial Hospital in Bolivar, Mo., begins offering breakthrough Alzheimer’s treatment
SPRINGFIELD, Mo. (KY3) - The first patients in southwest Missouri recently received a new treatment for Alzheimer’s.Staff at Citizens Memorial Hospital’s infusion center in...